SevenBridge Financial Group LLC purchased a new stake in shares of Roche Holding AG (OTCMKTS:RHHBY – Get Rating) during the second quarter, HoldingsChannel.com reports. The institutional investor purchased 52,375 shares of the company’s stock, valued at approximately $2,185,000.
Other large investors also recently bought and sold shares of the company. Fisher Asset Management LLC boosted its holdings in shares of Roche by 25.0% during the 1st quarter. Fisher Asset Management LLC now owns 5,823,906 shares of the company’s stock valued at $289,890,000 after acquiring an additional 1,165,391 shares during the last quarter. Sofinnova Investments Inc. bought a new position in Roche in the fourth quarter valued at about $70,764,000. Cullen Capital Management LLC grew its stake in shares of Roche by 11.8% during the 1st quarter. Cullen Capital Management LLC now owns 1,144,467 shares of the company’s stock valued at $56,548,000 after purchasing an additional 120,595 shares during the period. Cardinal Capital Management Inc. bought a new position in shares of Roche in the 1st quarter worth approximately $18,402,000. Finally, Osher Van de Voorde Investment Management grew its position in Roche by 21.0% during the first quarter. Osher Van de Voorde Investment Management now owns 357,068 shares of the company’s stock valued at $17,643,000 after buying an additional 61,989 shares during the period. 0.23% of the stock is currently owned by institutional investors.
Roche Price Performance
Shares of Roche stock opened at $42.35 on Monday. The firm’s 50-day moving average is $41.61 and its two-hundred day moving average is $43.82. Roche Holding AG has a 1 year low of $37.88 and a 1 year high of $53.86. The company has a current ratio of 0.93, a quick ratio of 0.73 and a debt-to-equity ratio of 0.57.
Analysts Set New Price Targets
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation.
- Get a free copy of the StockNews.com research report on Roche (RHHBY)
- Upwork Shares Stumble into Bargain Territory
- Kroger’s is Your One-Stop Consumer Staples Stock
- Adobe Perfects the Art of the Faceplant for Investors
- Tax Credits are the Incentives in the Inflation Reduction Act
- Stock Market: 3 Islands Of Strength In A Sea Of Red
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.